Osiris Therapeutics (OSIR)
Add to Watchlists Create an Alert
11.02
-0.05 -0.45%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Osiris Therapeutics Revenue Quarterly YoY Growth:
-7.46% for Dec. 31, 2012Osiris Therapeutics Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -7.46% |
| Dec. 31, 2012 | -71.80% |
| Sept. 30, 2012 | -77.46% |
| June 30, 2012 | -83.35% |
| March 31, 2012 | -56.07% |
| Dec. 31, 2011 | 2.59% |
| Sept. 30, 2011 | -1.72% |
| June 30, 2011 | 0.49% |
| March 31, 2011 | -8.31% |
| Dec. 31, 2010 | 0.10% |
| Sept. 30, 2010 | 1.64% |
| June 30, 2010 | -1.58% |
| March 31, 2010 | -10.60% |
| Dec. 31, 2009 | 74.66% |
| Sept. 30, 2009 | 963.7% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
OSIR Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Cytokinetics | -54.89% |
| Athersys | -10.76% |
| Cleveland BioLabs | 11.08% |
OSIR Revenue Quarterly YoY Growth Rankings
| Overall |
48th percentile 3886 of 7600 |
| Sector |
39th percentile 393 of 653 in Healthcare |
| Industry |
60th percentile 94 of 238 in Biotechnology |
OSIR Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -83.35% | Jun 2012 |
| Maximum | 3415% | Mar 2009 |
| Average | 293.6% |
